Increase of isoprostane 8-epi-PGF2α after restarting smoking

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 64, Issue 6, 2001, Pages 307-310

  Chehne, F ^a   Oguogho, A ^a   Lupattelli, G ^b   Budinsky, A C ^a   Palumbo, B ^b   Sinzinger, H ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ISOPROSTANE DERIVATIVE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; OXIDATION; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN URINE LEVEL; RISK FACTOR; SMOKING CESSATION;

EID: 0034928867     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0277     Document Type: Article

References (25)

1. The peripheral vascular consequence of smoking
2. Cardiovascular effects of long-term cigarette smoking and nicotine administration
3. Cigarette smoking and nonfatal myocardial infarction: Rate ratio in relation to age, sex and predisposing conditions
4. Smoking influences the atherogenic potential of low-density lipoprotein
5. Beyond cholesterol; modifications of low-density lipoprotein that increase its atherogenicity
6. Low-density lipoprotein oxidation and its pathobiological significance
7. 2-isoprostanes during oxidative modification of low-density lipoprotein
8. 2α in the arterial wall layers of various species - A comparison between intact and atherosclerotic arteries
9. Monocytes in human atherosclerotic plaque contain high levels of 8-epi-PGF2α: An index of oxidative stress in vivo
10. Isoprostanes in atherosclerotic lesions
11. 2α in human atherosclerotic vascular tissue
12. 2α in heterozygous hypercholesterolemia
13. Premature deaths avoided by the antismoking campaign
14. Isoprostane, eine neue substanzgruppe in der angiologie-in der zukunft von bedeutung?
15. The isoprostanes: Current knowledge and direction of future research
16. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma serum and urinary isoprostane)
17. 2-isoprostane excretion rate and diurnal variation in human urine
18. Modulation of oxidant stress in-vivo in chronic cigarette smokers
19. 2-isoprostanes in smokers. Smoking as a cause of oxidative damage
20. 2) biosynthesis in arteries
21. 2α
22. 2α is a potent contractor of human peripheral lymphatics
23. 2-isoprostane
24. 2-isoprostane, on endothelin-1 release
25. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets